Smarter Power, How EMS Engineering Moved Beyond Brute Intensity
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
Electrical stimulation stopped being an intensity problem decades ago, and everything interesting since has been about the shape of the signal rather than the size of it.
This article traces what actually changed, such as:
- The problem early stimulation could not solve
- Why the same signal stops working within one session
- What varying the frequency is designed to do
- Why amplitude is deliberately left alone
- What the evidence supports and what it does not
and many more!
By the end you will understand what smarter delivery means in practical terms.
Key Points:
Reaching the muscle is the easy part, and holding a session steady for ten minutes is the harder one.
A fixed signal repeated for ten minutes fades, because muscle and nerves both get used to it while the output stays the same.
Varying the frequency is designed to reduce that accommodation, and it cannot make accommodation impossible.
Amplitude is left under your control deliberately, so the strength you set is the strength you keep.
No trial has compared PureLift against any fixed-frequency device, so the case rests on category research and engineering.
Electrical stimulation is not a new technology, having been used in physical therapy, rehabilitation and sports medicine for decades before anyone pointed it at a face.
That long history is useful, because it means the interesting problems in this field were identified and worked on long before it became a beauty category.
The problem intensity could not solve
Getting a muscle to contract is straightforward once you can deliver enough current, and a review of kilohertz-frequency stimulation describes three separate thresholds in everyone, the point you feel the current, the point the muscle moves, and the point it hurts (Ward 2009).
Any competent device crosses the second threshold, and pushing toward the third buys discomfort rather than results.
So intensity was solved early, and the remaining problem was what happens across the minutes of a session rather than at any single instant.
Why the same signal stops working
Send a muscle the same fixed signal for ten minutes and it gets used to that signal, and your nerves get used to it too.
The device is still delivering exactly what it delivered at minute one, and your experience of it drops away, which is the moment people conclude a device has weakened.
That is accommodation, and it is the reason a fixed-frequency design can feel impressive at the start of a session and flat by the end.
Fixing it by turning the dial up mid-session is the intuitive response and the wrong one, since it treats a pattern problem as a power problem.
What varying the frequency does
The engineering answer is to stop the signal repeating.
PDM, the delivery architecture inside every PureLift, moves the signal across 361 frequency points between 1,370 and 1,730 Hz, so the pattern arriving at your muscle keeps changing through the session.
Pooling 22 studies, researchers found that stimulation which keeps changing produced more evoked force with less fatigue than a fixed pattern (Cavalcante 2026), and a randomised crossover trial found that varying the frequency reduced how quickly people habituated to it (Avendano-Coy 2019).
What that changes for you is the shape of the ten minutes rather than their strength, so if level 5 felt right at minute one it should feel about the same at minute nine.
Why amplitude is deliberately left alone
PDM varies frequency and does not vary amplitude or pulse duration, and that restraint is a design decision rather than a limitation.
Leaving amplitude under your control means the strength of your session stays exactly where you set it rather than drifting while you work, which makes it easier to keep comfortable and easier to compare week to week.
The research points the same way, since the work behind this approach found frequency variation more effective than pulse-duration variation at changing how quickly fatigue sets in, and found that benefit independent of amplitude.
A device that quietly moved your amplitude around would be harder to control and no more effective.
What the evidence supports, and what it does not
It supports the general conclusion that varied-frequency delivery reduces accommodation relative to constant-frequency delivery under tested conditions.
Not every study agrees, and one found variable trains tired muscle as much as constant ones (Papaiordanidou 2014).
It does not establish that any particular implementation prevents accommodation, guarantees a constant force, or produces a better cosmetic result than a fixed-frequency competitor.
No randomised trial has compared a PureLift against any fixed-frequency device, so our case rests on the category research and on the engineering rather than on a measured win.
A narrow claim that survives scrutiny is worth more than a broad one that does not.
What the muscle research supports separately
In the largest facial trial of its kind, 108 women used daily muscle stimulation for twelve weeks and ultrasound measured an 18.6 percent increase in cheek-muscle thickness, with a clear difference from the untreated group at six weeks (Kavanagh 2012).
A double-blind, sham-controlled trial in adults over 65 found muscle thickness and bite force increased after six weeks (Chang 2020), and CT imaging in a later study showed the muscle around the eye thickening after eight weeks (Okuda 2026).
Those studies establish that the muscle layer responds to training, which is a separate question from how the signal should be shaped.
Keeping the two questions apart is how you avoid using a fatigue study to support a cosmetic claim.
What has not changed
Contact still decides most of what arrives, so a dry or patchy conductive layer wastes more current than any engineering difference between two devices.
Consistency still decides the result, since the research timeline runs to twelve weeks and a device in a drawer performs identically to no device.
And the useful setting is still the one where you can see the muscle answer rather than the highest you can tolerate.
Better engineering improves the session you actually run, and it does not run the session for you.
Model notes
All five PureLift models run nanocurrent at level 1, microcurrent at level 2, EMS from level 3 to 10, and Infuse as a second pass, and all five carry PDM with the same 361 frequency points.
So the delivery architecture is identical across the range, and what differs between models is the top of the dial.
Face at $499 and Pro at $699 reach up to 7 milliamps, Pro Edition at $799 reaches up to 7.7, and Pro Plus + at $899 and GLOW at $999 reach up to 9, all measured at 500 ohms and always written as up to.
The session is three minutes on each side of the face, about ten minutes including the Infuse pass.
GLOW alone adds light, red at 634 nm cleared for the treatment of wrinkles, blue at 465 nm cleared for mild-to-moderate inflammatory acne, and purple, which is red and blue running together.
Every model is cleared through the FDA 510(k) pathway, under records K190269 for Face, K230506 for Pro and Pro Edition, K221443 for Pro Plus + and K243587 for GLOW, and all five are made in Japan in an ISO 13485 facility.
Anyone with a pacemaker or another implanted electronic device, anyone pregnant, and anyone with epilepsy or a seizure disorder should not use the device at all.
For where the category goes next, read the future of facial EMS, and for the two specifications, read frequency and output.
Model figures verified on 9 September 2026 against the PureLift LAB store and FDA records K190269, K230506, K221443 and K243587. Every model runs nanocurrent, microcurrent, EMS and Infuse; consumer copy always says up to.